| style="padding:10px; border-bottom:1px solid #dee2e6;" | Radiation Therapy
| style="padding:10px; border-bottom:1px solid #dee2e6;" | CAR-T Cell Therapy
...
14 KB (1,830 words) - 09:56, 6 April 2026
...ion=MSK treats 400+ mesothelioma cases annually with pioneering CAR T-cell therapy and clinical trials. Learn about treatment options and legal compensation.
...words=Memorial Sloan Kettering mesothelioma, MSK cancer center, CAR T-cell therapy mesothelioma, New York mesothelioma treatment, Prasad Adusumilli, Valerie R
...
29 KB (3,631 words) - 20:56, 20 February 2026
...67 discovery through 2020 immunotherapy approval to current CAR-T and gene therapy research.
* '''Survival Progress:''' From ~9 months untreated to 18+ months with modern therapy
...
20 KB (2,490 words) - 20:57, 20 February 2026
|title=CAR-T Cell Therapy for Mesothelioma: Clinical Trials, Targets & Outcomes
...ll therapy for malignant mesothelioma. Learn about mesothelin-targeted CAR-T cells, MSKCC clinical trial results showing 72% response rates, intrapleura
...
66 KB (8,673 words) - 02:53, 4 March 2026
|title=Mesothelioma Types: Pleural, Peritoneal, Pericardial & Cell Types Explained
...pes by location (pleural 75%, peritoneal 20%, pericardial, testicular) and cell type (epithelioid, sarcomatoid, biphasic). Symptoms, prognosis, treatment o
...
25 KB (3,138 words) - 20:56, 20 February 2026
| style="padding:10px;" | CAR-T, Gene Therapy
...fda-nivo-ipi" /> Today, researchers are exploring CAR-T cell therapy, gene therapy, and targeted treatments that offer hope for even greater survival improvem
...
38 KB (4,755 words) - 03:42, 9 March 2026
|title=Mesothelioma Clinical Trials 2026: 53 Active Trials, CAR-T, TEAD Inhibitors
...o 53 actively recruiting mesothelioma clinical trials in January 2026. CAR-T achieving 83% survival, first Phase III TEAD inhibitor, eligibility require
...
39 KB (4,791 words) - 23:07, 10 March 2026
...on approved CAR-T pricing for other cancers, though mesothelioma-specific therapy remains in clinical trials only
...is the most universally applied mesothelioma treatment, used as standalone therapy or combined with surgery and radiation as part of a [[Treatment Options|mul
...
39 KB (4,954 words) - 23:00, 8 March 2026
* '''Special Expertise:''' Sarcomatoid mesothelioma, cryoablation therapy
* '''Research Focus:''' CAR T-cell therapy, immunotherapy combinations, biomarker development
...
26 KB (3,157 words) - 20:56, 20 February 2026
...olumab-ipilimumab, pembrolizumab), radiation therapy, TTFields, CAR-T cell therapy, multimodal approaches, and palliative care.
...pneumonectomy, radiation therapy mesothelioma, TTFields mesothelioma, CAR-T mesothelioma, palliative care mesothelioma, mesothelioma clinical trials, A
...
55 KB (6,918 words) - 12:35, 6 April 2026
* '''Special Expertise:''' Sarcomatoid mesothelioma, cryoablation therapy
* '''Research Focus:''' CAR T-cell therapy, immunotherapy combinations, biomarker development
...
26 KB (3,216 words) - 14:57, 9 March 2026
...le:italic; border-bottom:1px solid #dee2e6;" | Immune Checkpoint Inhibitor Therapy
...t-line treatment for adults with unresectable MPM — the first new systemic therapy approved for mesothelioma in approximately 16 years, since pemetrexed plus
...
36 KB (4,570 words) - 09:56, 6 April 2026
...s''' for patients receiving advanced surgical approaches, while CAR-T cell therapy trials at Memorial Sloan Kettering achieve '''23.9 months median overall su
...'70+ clinical trials''' — actively recruiting studies including CAR-T cell therapy, bispecific antibodies, and TEAD inhibitors
...
38 KB (4,540 words) - 01:11, 6 April 2026
...2026, mesothelioma clinical trials, pleurectomy decortication surgeon, CAR T mesothelioma, mesothelioma immunotherapy
...="padding:10px; font-weight:bold; border-bottom:1px solid #dee2e6;" | Gene Therapy Research
...
63 KB (8,220 words) - 22:37, 8 March 2026
|title=Gene Therapy for Mesothelioma: Clinical Trials, Vectors & Outcomes
...for mesothelioma including suicide gene therapy (HSV-tk), interferon gene therapy (TR002 Phase 3), oncolytic virotherapy (ONCOS-102), tumor suppressor replac
...
67 KB (8,763 words) - 09:18, 6 April 2026
...ssification by location (pleural, peritoneal, pericardial, testicular) and cell type
...hift 2020-2026: CheckMate 743, pembrolizumab approval, MARS 2 trial, CAR-T therapy
...
23 KB (2,626 words) - 01:08, 6 April 2026
...ith dramatic variations based on disease location, stage at diagnosis, and cell type.<ref>[https://mesothelioma.net/mesothelioma-prognosis/ Mesothelioma Pr
| style="padding:10px; border:1px solid #dee2e6;" | '''Epithelioid cell type median survival'''
...
37 KB (4,489 words) - 20:45, 17 March 2026
...hemotherapy, immunotherapy combinations, surgical resection, and radiation therapy, with multimodal approaches combining these modalities offering the best ou
...herapy. Most patients with favorable performance status receive multimodal therapy combining two or more of these approaches in carefully sequenced protocols.
...
33 KB (3,904 words) - 20:57, 20 February 2026
...''' || C34 || Bronchogenic carcinoma (squamous cell, adenocarcinoma, small-cell) with asbestos etiology || Same staging as non-asbestos lung cancer; poor p
| '''Laryngeal Cancer''' || C32 || Squamous cell carcinoma of the larynx; causal relationship with asbestos established but
...
43 KB (5,354 words) - 03:51, 9 March 2026
...pecialized centers outlive those on supportive care alone''' — combination therapy with surgery, chemo, and immunotherapy can extend median survival beyond 2
| style="padding:10px; border-bottom:1px solid #dee2e6;" | '''CAR-T Phase I Response Rate'''
...
59 KB (7,425 words) - 01:11, 6 April 2026
